![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/durect-corporation-receives-fda-breakthrough-therapy-designation-for-larsucosterol-in-alcohol-associated-hepatitis-302150934.html
https://www.prnewswire.com/news-releases/durect-corporation-announces-topline-results-from-phase-2b-ahfirm-trial-of-larsucosterol-in-alcohol-associated-hepatitis-with-promising-effect-on-mortality-301980628.html
https://www.prnewswire.com/news-releases/durect-corporation-announces-last-patient-last-visit-in-phase-2b-ahfirm-trial-of-larsucosterol-in-alcohol-associated-hepatitis-301920265.html
https://www.clinicaltrialsarena.com/news/durect-concludes-enrolment-ah-therapy/
https://www.prnewswire.com/news-releases/durect-completes-enrollment-in-phase-2b-ahfirm-trial-of-larsucosterol-in-alcohol-associated-hepatitis-301844490.html